pulmonary fibrosis

Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.

The funding will support analyses of different tissue regions and cell types of IPF lungs, with the goal of better understanding the disease's pathogenesis.

Researchers at the University of Texas Southwestern Medical Center uncovered variants in two genes tied to pulmonary fibrosis and telomere shortening.

A group of researchers from several US institutions has identified a gene expression signature that can predict which patients with idiopathic pulmonary fibrosis are likely to have a worse outcome, based on how long they lived with the disease before death or before requiring a l

NEW YORK (GenomeWeb News) – In Nature Genetics, an international team led by investigators at the University of Minnesota described findings from a forward genetic screen aimed at uncovering mutations that drive the development of

The assay, which its developers claim can measure telomere length in less than half the time of other PCR-based methods while using 20-fold less genetic material, will be deployed as part of a clinical study designed to monitor changes in telomere length in response to certain therapies in patients with telomere diseases.

The research provides some short-term consumables revenue for Wafergen and validates its SmartChip real-time PCR system in advance of its full commercial launch, a company executive said.

Tech Transfer Tidbits

Premium

ImmuneRegen and U of Rochester tackle pulmonary fibrosis; Rutgers licenses biomaterials IP to Trident Biomed; Transgenomic licenses cold-PCR from Dana-Farber, and more …

Details of the deal are sparse, but the partners said they hope their research will lead to the development of genetic tests that can gauge patients’ predisposition to rare diseases and help target individuals most likely to respond to drugs made by MondoBiotech.

Short Reads

Premium

Broad Institute, Expression Analysis, Helicos BioSciences, University of Texas at Austin, Applied Biosystems, University of Georgia, ABRF, Genomatix, Illumina, Mondobiotech, 23andMe, Kapa Biosystems

Pages

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.